Abstract
The Posterior Reversible Encephalopathy Syndrome (PRES), is a rare entity that is associated with hypertension, autoimmune diseases and cancer drugs. We describe a 62 year old female patient with myasthenic crisis that following treatment with immunoglobulin G who presents neurological impairment, with initial MRI lesions suggestive of PRES, which were confirmed in control imaging. This entity should be considered in patients presenting with focal neurological impairment following the use of immunoglobulin.
References
BARTYNSKI WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008; 29:1036-42.
HAMILTON BE, NESBIT GM. Delayed CSF enhancement in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008;29:456-7.
AHN KJ, YOU WJ, JEONG SL, LEE JW, KIM BS, LEE JH, ET AL. Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology. 2004;46:978-83.
ELAHI A, KELKAR P, ST LOUIS EK. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré Syndrome. Neurocrit Care. 2004;1:465-8.
BAVIKATTE G, GABER T, ESHIETT MU. Posterior reversible encephalopathy syndrome as a complication of Guillain-Barré syndrome. J Clin Neurosci. 2010;17:924-6.
VAN DIEST D, VAN GOETHEM JW, VERCRUYSSEN A, JADOUL C, CRAS P. Posterior reversible encephalopathy and Guillain-Barre syndrome in a single patient: coincidence or causative relation? Clin Neurol Neurosurg. 2007;109:58-62.
OKEDA R, KAWAMOTO T, TANAKA E, SHIMIZU H. An autopsy case of drug-induced diffuse cerebral axonopathic leukoencephalopathy: the pathogenesis in relation to reversible posterior leukoencephalopathy syndrome. Neuropathology. 2007;27:364-70.
BELMOUAZ S, DESPORT E, LEROY F, TEYNIE J, HANNEQUIN J, AYACHE RA, ET AL. Posterior reversible encephalopathy induced by intravenous immunoglobulin. Nephrol Dial, Transplant. 2008;23:417-9.
NAKAJIMA M. Posterior reversible encephalopathy complicating intravenous immunoglobulins in a patient with miller-fisher syndrome. Eur Neurol. 2005;54: 58-60.
MAGAÑA SM, MATIELLO M, PITTOCK SJ, MCKEON A, LENNON VA, RABINSTEIN AA, ET AL. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 2009. 24;72:712-7.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.